Cleared Traditional

CerusEndo Microcatheter (K182487) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K182487 · Cerus Endovascular, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2019
Decision
312d
Days
Class 2
Risk

K182487 is an FDA 510(k) clearance for the CerusEndo Microcatheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Cerus Endovascular, Inc. (Fremont, US). The FDA issued a Cleared decision on July 20, 2019 after a review of 312 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Cerus Endovascular, Inc. devices

Submission Details

510(k) Number K182487 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 11, 2018
Decision Date July 20, 2019
Days to Decision 312 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
164d slower than avg
Panel avg: 148d · This submission: 312d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 344
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K182487.
SelectFlex 072 Neurovascular Access System
K191664 · Q'Apel Medical · Aug 2019
Turnpike Catheter
K191560 · Vascular Solutions, LLC · Aug 2019
Crossing Support Catheter
K183305 · Tractus Vascular, LLC · Aug 2019
087 Balloon Guide Catheter System
K190749 · Q'Apel · Jul 2019
Scepter Mini Occlusion Balloon Catheter
K182829 · MicroVention, Inc. · Jul 2019
Delivery Catheter SSPC1, Delivery Catheter SSPC2, Delivery Catheter SSPC3, Delivery Catheter SSPC4
K190475 · Centerpoint Systems · Jun 2019